243 related articles for article (PubMed ID: 2429668)
1. Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; Van Baal JM; De Vaan GA
Biochem Pharmacol; 1986 Oct; 35(20):3557-64. PubMed ID: 2429668
[TBL] [Abstract][Full Text] [Related]
2. Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; van Baal JM; Schretlen ED; De Bruijn CH
Biochem Pharmacol; 1988 Jun; 37(12):2329-38. PubMed ID: 2455520
[TBL] [Abstract][Full Text] [Related]
3. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts.
Bökkerink JP; Stet EH; De Abreu RA; Damen FJ; Hulscher TW; Bakker MA; van Baal JA
Biochem Pharmacol; 1993 Apr; 45(7):1455-63. PubMed ID: 7682415
[TBL] [Abstract][Full Text] [Related]
4. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH
Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667
[TBL] [Abstract][Full Text] [Related]
5. Effects of methotrexate on nucleotide pools in normal human T cells and the CEM T cell line.
Budzik GP; Colletti LM; Faltynek CR
Life Sci; 2000; 66(23):2297-307. PubMed ID: 10855951
[TBL] [Abstract][Full Text] [Related]
6. Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblasts.
Bökkerink JP; De Abreu RA; Stet EH; Damen FJ
Klin Padiatr; 1992; 204(4):293-8. PubMed ID: 1518268
[TBL] [Abstract][Full Text] [Related]
7. Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RA; Schretlen ED
Biochem Pharmacol; 1988 Jun; 37(12):2321-7. PubMed ID: 2455519
[TBL] [Abstract][Full Text] [Related]
8. Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides.
Quéméneur L; Gerland LM; Flacher M; Ffrench M; Revillard JP; Genestier L
J Immunol; 2003 May; 170(10):4986-95. PubMed ID: 12734342
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():174-80. PubMed ID: 7914720
[TBL] [Abstract][Full Text] [Related]
11. Studies on the incorporation of precursors into purine and pyrimidine nucleotides via 'de novo' and 'salvage' pathways in normal lymphocytes and lymphoblastic cell-line cells.
Marijnen YM; de Korte D; Haverkort WA; den Breejen EJ; van Gennip AH; Roos D
Biochim Biophys Acta; 1989 Jul; 1012(2):148-55. PubMed ID: 2787169
[TBL] [Abstract][Full Text] [Related]
12. [The effect of methotrexate on intracellular nucleotide pools].
Kawasaki H; Okubo T; Shimizu N; Komada M; Sako T; Hirota H; Noboru T; Kamiya H; Sakurai M; Izawa T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):485-92. PubMed ID: 4039917
[TBL] [Abstract][Full Text] [Related]
13. The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts.
Vogt MH; Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Trijbels FJ
Biochim Biophys Acta; 1993 Apr; 1181(2):189-94. PubMed ID: 7683208
[TBL] [Abstract][Full Text] [Related]
14. Purine and pyrimidine nucleotides in some mutant human lymphoblasts.
Nuki G; Astrin K; Brenton D; Cruikshank M; Lever J; Seegmiller JE
Ciba Found Symp; 1977; (48):. PubMed ID: 245991
[TBL] [Abstract][Full Text] [Related]
15. DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects.
Schwartsmann G; Peters GJ; Laurensse E; de Waal FC; Loonen AH; Leyva A; Pinedo HM
Biochem Pharmacol; 1988 Sep; 37(17):3257-66. PubMed ID: 2840910
[TBL] [Abstract][Full Text] [Related]
16. Purine and pyrimidine nucleotide concentrations in cells with decreased hypoxanthine-guanine-phosphoribosyltransferase (HGPRT) activity.
Nuki G; Astrin K; Brenton D; Cruikshank M; Lever J; Seegmiller JE
Adv Exp Med Biol; 1977; 76A():326-40. PubMed ID: 857617
[TBL] [Abstract][Full Text] [Related]
17. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors.
Fairbanks LD; Bofill M; Ruckemann K; Simmonds HA
J Biol Chem; 1995 Dec; 270(50):29682-9. PubMed ID: 8530356
[TBL] [Abstract][Full Text] [Related]
18. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells.
Sidi Y; Hudson JL; Mitchell BS
Cancer Res; 1985 Oct; 45(10):4940-5. PubMed ID: 2411392
[TBL] [Abstract][Full Text] [Related]
19. Development of a whole cell assay to measure methotrexate-induced inhibition of thymidylate synthase and de novo purine synthesis in leukaemia cells.
Barnes MJ; Taylor GA; Newell DR
Biochem Pharmacol; 2000 Feb; 59(4):321-8. PubMed ID: 10644039
[TBL] [Abstract][Full Text] [Related]
20. Effects of methotrexate on RNA and purine synthesis of astrocytes in primary culture.
Bruce-Gregorios JH; Agarwal RP; Oracion A; Ramirez A; Lin L
J Neuropathol Exp Neurol; 1991 Nov; 50(6):770-8. PubMed ID: 1721086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
